Publications by authors named "Tracy Lively"

Claim this Profile
C
Clinical and Genomic Risk for Late Breast Cancer Recurrence and Survival.
Joseph A Sparano, Michael Crager, Robert J Gray, Gong Tang, Jess Hoag, Tracy Lively

NEJM Evid· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial.
Kathy S Albain, Robert J Gray, Della F Makower, Amir Faghih, Daniel F Hayes, Tracy Lively

J Natl Cancer Inst· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution.
Orit Rozenblatt-Rosen, Aviv Regev, Philipp Oberdoerffer, Tal Nawy, Anna Hupalowska, Tracy Lively

Cell· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial.
Joseph A Sparano, Robert J Gray, Della F Makower, Kathy S Albain, Thomas J Saphner, Tracy Lively

JAMA Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing the dichotomy between individual and societal approaches to personalised medicine in oncology.
Roberto Salgado, David B Solit, David L Rimm, Jan Bogaerts, Renzo Canetta, Tracy Lively

Eur J Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
Joseph A Sparano, Robert J Gray, Peter M Ravdin, Della F Makower, Kathleen I Pritchard, Tracy Lively

N Engl J Med· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Next-Generation Sequencing Tests to Guide Cancer Treatment: Results From a Nationally Representative Survey of Oncologists in the United States.
Andrew N Freedman, Carrie N Klabunde, Kristine Wiant, Lindsey Enewold, Stacy W Gray, Tracy Lively

JCO Precis Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor DNA Assays in Clinical Cancer Research.
Miguel R Ossandon, Lokesh Agrawal, Eric J Bernhard, Barbara A Conley, Sumana M Dey, Tracy G Lively

J Natl Cancer Inst· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Tracy Lively

N Engl J Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers in early-phase trials: fundamental issues.
Laura M Yee, Tracy G Lively, Lisa M McShane

Bioanalysis· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steps forward for cancer precision medicine.
Roberto Salgado, Helen Moore, John W M Martens, Tracy Lively, Shakun Malik

Nat Rev Drug Discov· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Societal challenges of precision medicine: Bringing order to chaos.
Roberto Salgado, Helen Moore, John W M Martens, Tracy Lively, Shakun Malik

Eur J Cancer· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Tracy Lively

N Engl J Med· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A risk-management approach for effective integration of biomarkers in clinical trials: perspectives of an NCI, NCRI, and EORTC working group.
Jacqueline Anne Hall, Roberto Salgado, Tracy Lively, Fred Sweep, Anna Schuh

Lancet Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Criteria for the use of omics-based predictors in clinical trials.
Lisa M McShane, Margaret M Cavenagh, Tracy G Lively, David A Eberhard, William L Bigbee

Nature· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration.
Lisa M McShane, Margaret M Cavenagh, Tracy G Lively, David A Eberhard, William L Bigbee

BMC Med· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in drug and biomarker co-development.
Sheila E Taube, Tracy Lively

Recent Results Cancer Res· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging the gap: moving predictive and prognostic assays from research to clinical use.
P Michael Williams, Tracy G Lively, J Milburn Jessup, Barbara A Conley

Clin Cancer Res· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.
Mitch Dowsett, Torsten O Nielsen, Roger A'Hern, John Bartlett, R Charles Coombes, Tracy Lively

J Natl Cancer Inst· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study.

Nat Med· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer diagnostics: decision criteria for marker utilization in the clinic.
Sheila E Taube, James W Jacobson, Tracy G Lively

Am J Pharmacogenomics· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Program for the Assessment of Clinical Cancer Tests (PACCT): implementing promising assays into clinical practice.
J Milburn Jessup, Tracy G Lively, Sheila E Taube

Expert Rev Mol Diagn· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis